Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telithromycin vs Azithromycin Intrapulmonary Concentrations in Healthy Adults
NCT00315601Phase 4Terminated
- Sponsor
- University of Illinois Chicago
- Start
- Jan 2006
- Primary completion
- Nov 2006
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of telithromycin in community acquired pneumonia (CAP) (2 arms), sponsored by University of Illinois Chicago. Primary endpoints: Plasma drug concentrations at 7 days, Intrapulmonary drug concentrations at 7 days and 1 more. Started Jan 2006; status: terminated.
02
Drugs
telithromycin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT00315601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00315601.